230(top 1%)
papers
4.8K(top 1%)
citations
34(top 1%)
h-index
64(top 1%)
g-index
266
all documents
5.2K
doc citations
1.4K
citing journals

Top Articles

#TitleJournalYearCitations
1Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and ImidazoquinolinesJournal of Immunology2011516
2EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndromeAnnals of the Rheumatic Diseases2011383
3The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter studyJournal of Thrombosis and Haemostasis2009260
4Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Annals of the Rheumatic Diseases2016225
5Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)Annals of the Rheumatic Diseases2015193
6Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working GroupRMD Open2018155
7Phage Display: Selecting Straws Instead of a Needle from a HaystackMolecules2011150
8EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritisAnnals of the Rheumatic Diseases2012148
9Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolismEuropean Journal of Clinical Pharmacology2008114
10Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritisBiological Chemistry2010101
11Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patientsEuropean Journal of Clinical Pharmacology200883
12Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as a biomarker?Arthritis Research and Therapy201281
13Autoimmune response following annual influenza vaccination in 92 apparently healthy adultsAutoimmunity Reviews200875
14Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesiclesScience Signaling201574
15Adiponectin is an endogenous anti-fibrotic mediator and therapeutic targetScientific Reports201764
16Autoantibodies in Nonautoimmune Individuals during InfectionsAnnals of the New York Academy of Sciences200763
17Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patientsArthritis Research and Therapy201262
18Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?Autoimmunity Reviews201562
19Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)Lupus201359
20Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaborationAnnals of the Rheumatic Diseases201958
21Prevalence of Sjogren's syndrome in SloveniaBritish Journal of Rheumatology199955
22The Ped-APS Registry: the antiphospholipid syndrome in childhoodLupus200954
23Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre studyLupus201753
24IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adultsArthritis Research and Therapy201650
25Binding of plasma proteins to titanium dioxide nanotubes with different diametersInternational Journal of Nanomedicine201549
26Influence of foot orthoses on plantar pressures, foot pain and walking ability of rheumatoid arthritis patients–a randomised controlled studyDisability and Rehabilitation200947
27Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated reviewAutoimmunity Reviews201244
28Does leflunomide have a role in giant cell arteritis? An open-label studyClinical Rheumatology201944
29Incidence of IgA vasculitis in the adult Slovenian populationBritish Journal of Dermatology201443
30The role of colour doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: A prospective studyEuropean Journal of Radiology201740
31Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurementsClinical Rheumatology201940
32The cut-off values for the intima–media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteriesRheumatology202140
33Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy OutcomesJournal of Immunology Research201539
34An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosisScientific Reports201839
35Mechanical stability of membrane nanotubular protrusions influenced by attachment of flexible rod-like proteinsJournal of Biomechanics201038
36Titanium Dioxide Nanotube Arrays for Cardiovascular Stent ApplicationsACS Omega202035
37Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic SclerosisPLoS ONE201534
38Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationRMD Open202033
39Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic diseaseLupus201232
40Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patientsClinical Rheumatology201932
41Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the ModelsFrontiers in Pharmacology201831
42Prolactin’s role in the pathogenesis of the antiphospholipid syndromeLupus201028
43Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaborationAnnals of the Rheumatic Diseases202128
44Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patientsPharmacogenomics201227
45Predicting gastrointestinal and renal involvement in adult IgA vasculitisArthritis Research and Therapy201927
46Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseasesBlood Cells, Molecules, and Diseases200826
47Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS ProjectFrontiers in Medicine202026
48Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registryClinical Rheumatology201525
49Clinical Approach to Diagnosis and Therapy of Polyarteritis NodosaCurrent Rheumatology Reports202125
50Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous ImmunoglobulinCase Reports in Dermatology201323